Derivative Type: Bovine pancreatic deoxyribonuclease
Trademarks: Deanase (Consolidated Chem.); Dinase (Eufarma); Dornavac (Merck Co.)
Properties: Mixture of 4 isoforms. DNAse A is the most predominant. Contains 257 amino acid residues; mol wt 31 kDa. pI ~5.
Derivative Type: Dornase alfa
CAS Registry Number: 143831-71-4
CAS Name: Deoxyribonuclease (human clone 18-1 protein moiety)
Additional Names: rhDNase I
Trademarks: Pulmozyme (Genentech)
Literature References: Human DNase I produced in Chinese hamster ovary cells by recombinant DNA technology. Cloning and expression of human form and effect on sputum viscosity: S. Shak et al., Proc. Natl. Acad. Sci. USA
87, 9188 (1990); S. Shak,
WO
9007572 (1990 to Genentech). HPLC purification: J. Cacia et al., J. Chromatogr.
634, 229 (1993). Clinical study in cystic fibrosis: H. J. Fuchs et al., N. Engl. J. Med.
331, 637 (1994). Expert report on pharmacology and toxicology: J. D. Green, Hum. Exp. Toxicol.
13, Suppl. 1, S1-S42 (1994).
Therap-Cat: Debriding agent. In treatment of cystic fibrosis and other pulmonary disease to reduce viscosity of sputum.
Therap-Cat-Vet: Debriding agent.
Keywords: Debriding Agent.
产品链接: 9003-98-9››